A Multi-National Survey on Immunosuppressive Regimens and Mycophenolate Monitoring Practices after Kidney Transplantation
Across distinct geographic regions, immunosuppression regimen including tacrolimus, MMF, and long-term corticosteroids in standard risk kidney transplant recipients was homogenous. MPA concentration measurement to guide therapy is rarely used in India, though not uncommon across Australia and New Zealand at least in specific circumstances. Overcoming practical barriers and ensuring accessible clinical guidance may provide opportunities to improve the uptake of MPA monitoring.
Authors
- Simon S. Craig (ORCID: https://orcid.org/0000-0003-2594-1643)
- Sonia Sharma (ORCID: https://orcid.org/0000-0003-2128-7488)
- Joshua Kausman
- David Metz (ORCID: https://orcid.org/0000-0003-4478-5308)
Institutions
- Royal Children's Hospital (AU)
- The University of Melbourne (AU)
- Monash Medical Centre (AU)
- Monash Children’s Hospital (AU)
- Monash Health (AU)
- Murdoch Children's Research Institute (AU)
- Monash University (AU)
Publication Details
- Journal
- Kidney & Blood Pressure Research
- Published
- 2025-12-12
- DOI
- https://doi.org/10.1159/000549997
- Primary Topic
- Renal Transplantation Outcomes and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Monash University
- Medical Research Council
- National Health and Medical Research Council